VOL. 12, NO. 11 • NOVEMBER 2019 Dear Colleagues: Welcome to the November 2019 issue of The Journal of Clinical and Aesthetic Dermatology. We begin the issue with results from
J Clin Aesthet Dermatol. 2019;12(11):13–18 by James Q. Del Rosso, MD; Linda Stein Gold, MD; Jeanett Segal; and Andrea L. Zaenglein, MD Dr. Del Rosso is with JDR Dermatology Research/Thomas Dermatology
J Clin Aesthet Dermatol. 2019;12(11):20–22 by Ritu Swali, MD, and Monica Lee, BS Dr. Swali is with the Department of Medicine at the University of California, Irvine in Irvine, California.
J Clin Aesthet Dermatol. 2019;12(11):23–26 by Sabeen Yaqub, MD; Shelly A. Stepenaskie, MD; Fatemeh Jafari Farshami, MD; Wilmer L. Sibbitt Jr., MD; Monthida Fangtham, MD; N. Suzanne Emil, MD; and Arthur D.
J Clin Aesthet Dermatol. 2019;12(11):28–31 by Sherine Hosny Ahmed Abdel Rahman, MD; Mohamed Saber Hussein, MD; and Amira Ibrahim Mansour, MD Drs. Ahmed, Hussein, and Mansour are with the Faculty
J Clin Aesthet Dermatol. 2019;12(11):32–34 by Bruna Souza Felix Bravo, MD; Julien Totti de Bastos, MD; Camila Roos Mariano de Rocha, MD; Berta Alcala, MD; Stephanie Bianco, MD; Fernando Luis Lopes
J Clin Aesthet Dermatol. 2019;12(11):35–44 by Athanasios J. Stefanis, MD, MPharm; Tomas Groh, MSc, PhD; Monika Arenbergerova, MD, PhD; Petr Arenberger, MD, PhD; and Peter O. Bauer, MD, PhD Drs. Stefanis,
Objective. We sought to evaluate the safety, tolerability, and patterns of use for the once-daily oral, narrow-spectrum antibiotic sarecycline in patients with moderate-to-severe acne vulgaris during a 40-week Phase III, multicenter, open-label extension study.